Voriconazole – Page 3

Dual fungal endocarditis in a pediatric dialysis patient: First case of Aspergillus flavus and Candida parapsilosis co-infection

mycolabadmin

A 13-year-old boy with kidney disease requiring dialysis developed a rare dual fungal heart infection caused by two different fungi simultaneously. Doctors diagnosed the infection using heart imaging, blood tests, and tissue examination, then treated him with antifungal medications and two heart surgeries to remove infected tissue and replace a damaged heart valve. Despite the extreme rarity and severity of this condition, the patient survived, which had never been reported in children before.

Black mold in the bag room: First case of Arthrocladium tropicale peritonitis in a peritoneal dialysis patient

mycolabadmin

An 82-year-old dialysis patient developed an unusual infection caused by a black mold called Arthrocladium tropicale, which had never been documented in humans before. The infection was traced to poor storage conditions and ant infestations near the patient’s dialysis supplies in Thailand during rainy season. Doctors identified the rare fungus using molecular genetic testing and treated it successfully with antifungal medication combined with removal of the dialysis catheter. This case highlights the importance of keeping dialysis equipment in clean, dry environments and preventing pest access to prevent serious infections.

Azole Resistance in Aspergillus Species Isolated from Clinical Samples: A Nine-Year Single-Center Study in Turkey (2015–2023)

mycolabadmin

This study examined azole antifungal resistance in fungal infections from a Turkish hospital over nine years. Researchers tested 200 Aspergillus fungal isolates and found that 7% showed resistance to azole medications, with 11% of Aspergillus fumigatus showing resistance. The findings highlight the ongoing challenge of drug-resistant fungal infections and the importance of monitoring resistance patterns to improve treatment decisions for serious fungal infections.

First case of invasive Rasamsonia argillacea in a child with chronic granulomatous disease in Qatar

mycolabadmin

A 16-year-old girl with a rare immune system disorder called chronic granulomatous disease developed a serious fungal infection caused by Rasamsonia argillacea, a fungus that is not commonly seen in clinical practice. The infection presented as a painful collection in her chest wall that required surgery and multiple antifungal medications. This is the first reported case of this particular fungal infection in the Arabian Peninsula, and successful treatment required a combination of drugs chosen based on laboratory testing of the fungus’s resistance patterns.

Distribution of fungal agents in the respiratory system of patients with underlying lung diseases; molecular identification and antifungal susceptibility profiles

mycolabadmin

This research examined fungal infections in hospitalized patients with lung diseases in Iran, identifying which fungi were most common and which antifungal medications worked best against them. Researchers found that Candida albicans and Aspergillus flavus were the most prevalent fungi, particularly in COPD patients. Notably, some Candida isolates showed resistance to certain antifungal drugs, particularly voriconazole. The study emphasizes the importance of proper fungal identification and susceptibility testing for effective treatment.

Deep cutaneous fungal infection in an immunocompetent individual caused by a biological pesticide: a rare case report

mycolabadmin

A 66-year-old farmer developed recurring skin infections over 10 years from exposure to a biological pesticide containing a fungus called Purpureocillium lilacinum. Although this fungus is generally safe for healthy people, this case shows it can cause serious skin infections with prolonged exposure. The patient was successfully treated with antifungal medication over three months. This case highlights the importance of proper safety measures when working with biological pesticides.

Infection caused by a cryptic fungal species, Blastomyces gilchristii, in a tiger

mycolabadmin

A tiger at a veterinary hospital developed a serious fungal infection that affected its brain and lungs. Using advanced DNA sequencing technology, researchers identified the infection was caused by a previously unrecognized fungal species called Blastomyces gilchristii. This discovery was important because it showed that this dangerous fungus exists in areas where scientists previously thought it wasn’t found, and it highlights the importance of using modern genetic testing to identify unusual infections.

Acute Respiratory Distress Syndrome Due to COVID-19-Associated Pulmonary Aspergillosis with Rare Extensive Tracheobronchial Pseudomembranous Involvement: A Case Report

mycolabadmin

An 87-year-old man with COVID-19 developed a rare and severe fungal infection in his airways caused by Aspergillus fumigatus. Doctors used a camera tube (bronchoscope) to see thick, yellowish-white membrane-like material coating his entire windpipe and airways, which is an extremely rare complication. Despite starting antifungal medications, his condition rapidly worsened leading to organ failure and death. This case highlights how COVID-19 can leave patients vulnerable to serious secondary fungal infections that require immediate recognition and treatment.

Antifungal susceptibility testing of Microsporum canis isolated from the skin of dermatologically healthy cats

mycolabadmin

Researchers tested healthy cats in Chile and found that about 5% carried a fungus called Microsporum canis that can cause ringworm. This fungus was resistant to a common antifungal drug called fluconazole. Indoor cats were more likely to carry the fungus than outdoor cats. Because cats can spread this fungus to people, identifying carrier cats is important for preventing human infections.

Localized Versus Diffuse Corneal Invasion in Fungal Keratitis: Histological Insights from Candida albicans and Fusarium falciforme

mycolabadmin

This study compared how two types of fungi invade the cornea of the eye. Candida albicans, a yeast, stayed localized to where it entered the eye and was easier to control surgically. In contrast, Fusarium falciforme, a mold, spread aggressively throughout the entire cornea and was much harder to treat. Understanding these different invasion patterns helps explain why some fungal eye infections are more difficult to manage than others.

therapeutic action: Voriconazole